Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-((1r)-1-((6-amino-5-chloropyrimidine-4-carbonyl)amino)ethyl)-n-(5-chloro-4-(trifluoromethyl)pyridin-2-yl)-1,3-thiazole-5-carboxamide
2. Mln 2480
3. Mln2480
4. Tak-580
1. 1096708-71-2
2. Mln2480
3. Biib-024
4. Tak-580
5. Mln 2480
6. Mln-2480
7. Biib024
8. Tovorafenib
9. Biib 024
10. Day101
11. Tovorafenib [usan]
12. Tak-580 (mln2480)
13. Tak 580
14. Amg 2112819
15. Tak580
16. Zn90e4027m
17. 2-[(1r)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-n-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide
18. 6-amino-5-chloro-n-((1r)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl)-4-pyrimidinecarboxamide
19. 6-amino-5-chloro-n-[(1r)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide
20. 4-pyrimidinecarboxamide, 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-
21. Unii-zn90e4027m
22. 4-pyrimidinecarboxamide, 6-amino-5-chloro-n-((1r)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl]-
23. 6-amino-5-chloro-n-[(1r)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide
24. Qop
25. Tovorafenib [inn]
26. Gtpl9977
27. Schembl4206123
28. Chembl3348923
29. Tak 580 [who-dd]
30. Day-101
31. Dtxsid70149011
32. Ex-a940
33. Chebi:167672
34. 4-pyrimidinecarboxamide, 6-amino-5-chloro-n-((1r)-1-(5-(((5-chloro-4-(trifluoromethyl)-2-pyridinyl)amino)carbonyl)-2-thiazolyl)ethyl)-
35. Bcp13797
36. Mfcd22571730
37. Nsc766906
38. Nsc800798
39. S7121
40. Who 11985
41. Zinc43202464
42. Mln 2480(biib-024)
43. Akos027323782
44. Amg2112819
45. Ccg-269746
46. Cs-0751
47. Db15266
48. Nsc-766906
49. Nsc-800798
50. Amg-2112819
51. Ncgc00346458-01
52. Ncgc00346458-02
53. Example 10da [us20090036419]
54. Hy-15246
55. P13369
56. J-690031
57. Q27295775
58. (2z,3z)-bis{amino[(2-aminophenyl)sulfanyl]methylene}succinonitrile - Ethanol (1:1)
| Molecular Weight | 506.3 g/mol |
|---|---|
| Molecular Formula | C17H12Cl2F3N7O2S |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 505.0102337 g/mol |
| Monoisotopic Mass | 505.0102337 g/mol |
| Topological Polar Surface Area | 164 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 695 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Tovorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tovorafenib, including repackagers and relabelers. The FDA regulates Tovorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tovorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tovorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tovorafenib supplier is an individual or a company that provides Tovorafenib active pharmaceutical ingredient (API) or Tovorafenib finished formulations upon request. The Tovorafenib suppliers may include Tovorafenib API manufacturers, exporters, distributors and traders.
click here to find a list of Tovorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tovorafenib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tovorafenib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tovorafenib GMP manufacturer or Tovorafenib GMP API supplier for your needs.
A Tovorafenib CoA (Certificate of Analysis) is a formal document that attests to Tovorafenib's compliance with Tovorafenib specifications and serves as a tool for batch-level quality control.
Tovorafenib CoA mostly includes findings from lab analyses of a specific batch. For each Tovorafenib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tovorafenib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tovorafenib EP), Tovorafenib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tovorafenib USP).
LOOKING FOR A SUPPLIER?
